CHRONIC RENAL FAILURE online presentation

SyedaAliya27 29 views 66 slides Sep 02, 2024
Slide 1
Slide 1 of 66
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53
Slide 54
54
Slide 55
55
Slide 56
56
Slide 57
57
Slide 58
58
Slide 59
59
Slide 60
60
Slide 61
61
Slide 62
62
Slide 63
63
Slide 64
64
Slide 65
65
Slide 66
66

About This Presentation

All about chronic renal failure


Slide Content

1 THE KIDNEY

Reddish-brown, bean shaped 11-12cm long, 6cm wide, 4cm thick AT level of T 12 to L 3 Retroperitoneal & against the dorsal body wall Right kidney is slightly lower than left Attached to ureters, renal blood vessels and nerves at renal hilus On the top of each kidney there is an adrenal gland 2 ANATOMY OF KIDNEY

A frontal section through kidney reveals two distinct regions: R enal cortex : superficial, light red region R enal medulla : deep, darker reddish-brown and consists of several cone-shaped renal pyramids. B ase of each pyramid faces renal cortex, and its apex, called a renal papilla, points toward the renal hilum . 3 ANATOMY OF KIDNEY

R enal cortex is extending from renal capsule to bases of renal pyramids and into the spaces between them and divided into outer-cortical zone and inner-juxtamedullary zone. Renal columns of Bertini : P ortions of renal cortex that extend between renal pyramids are called RENAL PARENCHYMA : renal cortex and renal pyramids of renal medulla. Within the parenchyma, functional units of the kidney-microscopic structures called nephrons. 4 ANATOMY OF KIDNEY

5

Filtrate by nephrons drains into large papillary ducts . P apillary ducts drain into cuplike structures called minor and major calyces. Each kidney has 8 to 18 minor calyces and 2 or 3 major calyces. A minor calyx receives filtrate from the papillary ducts of one renal papilla and delivers it to a major calyx. 6 ANATOMY OF KIDNEY

Once the filtrate enters the calyces it becomes urine because no further reabsorption can occur. From the major calyces, urine drains into a single large cavity called the renal pelvis and then out through the ureter to the urinary bladder. 7 ANATOMY OF KIDNEY

Structural and functional units of the kidneys Over 1 million Responsible for forming urine Consist of Renal corpuscle: Knot of capillaries called Glomerulus Renal tubule: PCT DLOH ALOH DCT CD 8 NEPHRONS

9 FUNCTIONS OF NEPHRON

Consists of an anastomosing network of capillaries lined by fenestrated endothelium invested by two layers of epithelial cells. Visceral epithelial cells Parietal epithelium 10 STRUCTURE OF GLOMERULUS

Visceral epithelial cells (podocytes ) : incorporated into and become an intrinsic part of the capillary wall, separated from endothelial cells by a BM. Parietal epithelium : situated on the Bowman capsule, lines urinary space in which plasma filtrate first collects. STRUCTURE OF GLOMERULUS

The glomerular capillary wall is the filtering membrane and consists of Fenestrated endothelial cells : with each fenestra being about 70 to 100 nm in diameter . Glomerular basement membrane (GBM ) Podocytes 12 Glomerular filtration barrier

Glomerular basement membrane (GBM) : Consist of 3 layers Lamina rara interna : inner thin layer Lamina densa : thick layer Lamina rara externa: outer dense layer Podocytes processes embedded in BM Adjacent foot processes of podocytes are separated by 20- to 30-nm–wide filtration slits.

GBM consists of collagen (mostly type IV), laminin, polyanionic proteoglycans (mostly heparan sulfate) & several other glycoproteins. Type IV collagen forms a network to which other glycoproteins attach. 14 GLOMERULAR BASEMENT MEMBRANE

Monomer of this network is a triple-helical molecule composed of six types of α chains (α1 to α6 or COL4A1 to COL4A6). GLOMERULAR BASEMENT MEMBRANE

Each molecule consists of : 7S domain at the N terminus, Triple-helical domain in the middle& Noncollagenous (NC1) domain at the C terminus. The NC1 domain is important for helix formation and for assembly of collagen monomers into the BM. GLOMERULAR BASEMENT MEMBRANE

Entire glomerular tuft is supported by the MESANGIUM. Cells of mesenchymal origin are contractile , phagocytic capable of proliferation , laying down both matrix and collagen, and secreting several biologically active mediators. 17

Glomerular filtration Pressure differences result in a gradient and movement of solutes across the semipermeable glomerular basement membrane. 18

Glomerulus is highly permeable to water & small solutes because of the fenestrated nature of the endothelium. The permeability characteristics of the glomerular filtration barrier varies: depending on their size (the larger, the less permeable ) charge (the more cationic, the more permeable) 19 GLOMERULAR FILTRATION

The visceral epithelial cell is important for the maintenance of glomerular barrier function; slit diaphragm presents a size-selective distal diffusion barrier to the filtration of proteins. 20 GLOMERULAR FILTRATION

Within cytoplasm of the foot processes, nephrin forms connections with podocin, CD2-associated protein &ultimately actin cytoskeleton of visceral epithelial cells. mutations in genes encoding them give rise to defects in permeability and the nephrotic syndrome. 21

Edema Renal hypertension Flank pain& renal colic Lower urinary tract symptoms Uremia - Azotemia 22 CLINICAL MANIFESTATION OF RENAL DISEASES

Acute kidney injury Nephrotic syndrome Nephritic syndrome Isolated haematuria or proteinuria Chronic kidney diseases End stage renal diseases 23 SYNDROMES OF RENAL DISEASES

CHRONIC RENAL FAILURE

Progressive and irreversible loss of renal function over time, based on a gradual decline in the GFR and creatinine clearance ,frequently leading to end stage renal disease ( ESRD). I n which the body’s ability to maintain metabolic and fluid and electrolyte balance fails resulting in uremia or azotemia. DEFINITION

Multiple terms have been applied to chronic renal failure all of these terms are replaced with CKD It encompasses the continuum of kidney dysfunction from mild kidney damage to kidney failure, and includes end-stage renal disease (ESRD). CRF=CRI=CRD= CKD

ESTABLISHED CHRONIC KIDNEY DISEASE

A clinical state or condition in which there has been an irreversible loss of renal function, and these patients usually need to accept renal replacement therapy in order to avoid life-threatening uremia END STAGE RENAL DISEASE

The diseases leading to CRF can generally be classified into two major groups : those causing glomerular pathology those causing tubulointerstitial pathology ETIOLOGY

Primary glomerular pathology Systemic glomerular pathology Diseases causing glomerular pathology

Primary glomerular pathology : The major cause of CRF is chronic glomerulonephritis. various types of glomerulonephritis such as membranous glomerulonephritis, membranoproliferative glomerulonephritis , lipoid nephrosis (minimal change disease) anti-glomerular basement membrane nephritis. Diseases causing glomerular pathology

ii) Systemic glomerular pathology : Certain conditions originate outside the renal system but induce changes in the nephrons secondarily. Major examples of this type are systemic lupus erythematosus and diabetic nephropathy Diseases causing glomerular pathology

categorised according to initiating etiology into 4 groups : vascular - essential hypertension produces characteristic changes in renal arteries and arterioles referred to as nephrosclerosis Infectious - chronic pyelonephritis Toxic - analgesics Obstructive - stones , blood clots, tumours , strictures and enlarged prostate Diseases causing tubulointerstitial pathology

MOST COMMON CAUSES

PATHOPHYSIOLOGY OF CHRONIC RENAL FAILURE

PATHOPHYSIOLOGY Due to etiological factors renal function declines. N eph r on dama g e i s p r o g ess i v e dama g e ne p h r on can not function and to not recover. Decreased glomerular filtration rate. R emai n i n g neph r o n s unde r g o chan g e.

To compensate for those damaged nephrons. C ompensa t o r y e x c r et io n c on t inu e GFR di m in i shed. Filtration of more concentrated blood by the remaining nephrons. Damage of nephron results in hypertrophy and hyper phosphatenia of remaining nephron. Urine may contain abnormal amount of protein RBCs, white bloo d c ells or cast s .

Increased serum creatinine bun level and retention of urea and other introgenous F u ther dam a g e of th e ne p h r on 8 -90 % dam a g e C FR 10-20%. Tha n lead t o ch r o n i c r enal fa i lu r e.

PATHOGENESIS

CLINICAL MANIFESTATION OF CHRONIC RENAL FAILURE

Alterations in Fluids and Electrolytes

Alterations in Fluids and Electrolytes

METABOLIC ACIDOSIS

ANEMIA

HEMATOLOGIC CHANGES ANEMIA, FATIGUE, WEAKNESS, COLD INTOLERANCE AS KIDNEYS ARE TO PRODUCE ERYTHROPOIETIN BLEEDING TENDENCIES AS ACCUMULATION OF UREMIC INTERFERE WITH PLATLET ADHESIVENESS. HEMOLYSIS, CLOTTING ABNORMALITIES.

Firstly: kidney fail to excrete phosphate. Hyperphosphatemia 4 - RENAL OSTEODYSTROPHY Secondary : high parathyroid hormone levels.

Early stages (1-2-3) hyperphosphate mia Hy p o c a lc a emia Later stages( 4-5) decreased synthesis of 1α-hydroxylase 4 - RENAL OSTEODYSTROPHY by negative feedback.

RENAL OSTEODYSTROPHY

RENAL OSTEODYSTROPHY

OSTEOPOROSIS OSTEOSCLEROSIS OSTEOMALACIA OSTEITIS FIBROSA RENAL OSTEODYSTROPHY

INTEGUMENTORY CHANGES:- SKIN-VERY DRY BECAUSE OF ATROPHY OF SWEAT GLAND. PRURITIS-EXCORIATED SKIN. SKIN COLOR-UROCHROMS PIGMENTS. MUEHRCKE’S LINE UREMIC FROST

RESPIRATORY CHANGES PULMONARY EDEMA. UREMIC LUNG METABOLIC ACIDOSIS AS A RESULT OF RESPIRATORY CHANGES TO HYDROGEN IONS .

C OMPLICATIONS OF UREMIA Uremia-induced platelet dysfunction Uremic pe r ic a rd i tis Uremic enc e ph a l o pathy Increased tendency to bleed and ecchymosis Ecchymosis, GI bleeding Chest pain, malaise H e ad a ches, confusion, coma Per i c a r d ia l friction rub

L O S S O F EX CR E T O R Y R E N A L F UNC T I O N S D E C R EASE D LI B IDO INFERTILITY D E L A YE D H E ALI NG INFECTION A D V A N C E D A T H E R O S C LE R O SIS E R R A TIC BL O O D G L U C O S E LE V EL A N E M IA , P AL L OR DECREASED CALCIUM ABSORPTION:- OSTEODYSTR O PHY AND HYPOCALCE M IA DISTU R B A N C ES IN REPRODUCTION IMM UNE DISTU R B A N C ES IN C REA SED PRO D U C TION O F LIPI D S IM P AIRED INS U LI N ACTION F AI L U R E T O PRO D U C E ERYTHROPOIETIN F AI L U R E T O C O N V E R T INA C TI V E FOR M S OF CALCIUM

LOSS OF NON-EXCRETORY RENAL FUNCTIONS METABOLIC ACIDOSIS DECREASED HYDROGEN SECRETION AND DECREASED BICARBONATE REABSORPTION HYPERPHOSPHATEMIA→DECREASED CALCIUM ABSORPTION→ HYPOCALCEMIA→ HYPER-PARATHYROIDISM→ DECREASED POTASSIUM EXCRETION→ HYPERLKALEMIA DECREASED PHOSPHATE EXCRETION HYPERKALEMIA DECREASED POTASSIUM EXCRETION WATER RETENTION CAUSING HYPERTENSION, HEART FAILURE, EDEMA DECREASED SODIUM REABSORPTION IN TUBULE UREMIA CAUSING INCREASED BUN, CREATININE, URIC ACID, PROTEINURA, PERIPHERAL NERVE CHANGES, PERICARDITIS, PRURITIS, CNS CHANGES, BLEEDING TENDENCIES DECREASED EXCRETION OF NITROGENOUS WASTE

C HRONIC K IDNEY CLINICAL MANIFESTATIONS And C OMPLICATIONS OF UREMIA

DIAGNOSTIC EVALUATION History taking. Physical examination. Blood testing. Urine testing. Electrocardiogram. Imaging test. Kidney biopsy. Renal function test.

AIM OF TREATMENT

P REVENTION OF FURTHER DETERIORATION T REAT COMPLICATION 3. E STABLISHMENT OF TREATMENT STRATEGY FOR ESRD AIM OF TREATMENT

DIETARY INTERVENTIONS FLUID ALLOWANCE 500-600ml (or) MORE THAN THE PREVIOUS DAY 24hrs Urine Output. Carbohydrate & Fat Intake 40 - 50kcal/Kg/Day. Diet Restriction Protein 1g/Kg/Day. Vitamin Supplements.

ADMINISTRATION OF Anti-hypertensives Erythropoietin Iron Supplements Phosphate Binding Agents Calcium Supplements Adequate Dialysis

HYPERKALEMIA Dialysis Therapy Potassium Removal Potassium Restricted Diet

SURGICAL MANAGEMENT